These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21955331)

  • 1. Quality of medical devices and in vitro diagnostics in resource-limited settings.
    Mori M; Ravinetto R; Jacobs J
    Trop Med Int Health; 2011 Nov; 16(11):1439-49. PubMed ID: 21955331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing operational readiness: Regulatory landscape and compliance in zimbabwe for medical devices and in vitro diagnostic medical devices.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287495. PubMed ID: 38753597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating regulatory landscape: A qualitative exploration of medical devices and in vitro diagnostic medical devices oversight in Zimbabwe through key stakeholder perspectives.
    Chiku C; Maruta T; Mbiba F; Manasa J
    PLoS One; 2024; 19(5):e0287415. PubMed ID: 38753856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative newborn health technology for resource-limited environments.
    Thairu L; Wirth M; Lunze K
    Trop Med Int Health; 2013 Jan; 18(1):117-28. PubMed ID: 23279380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-cost technologies for medical diagnostics in low-resource settings.
    Balsam J; Ossandon M; Bruck HA; Lubensky I; Rasooly A
    Expert Opin Med Diagn; 2013 May; 7(3):243-55. PubMed ID: 23480559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?
    Favaloro EJ; Plebani M; Lippi G
    Clin Chem Lab Med; 2011 Aug; 49(12):1965-73. PubMed ID: 21875399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new European directive on in vitro diagnostics.
    Dati F
    Clin Chem Lab Med; 2003 Oct; 41(10):1289-98. PubMed ID: 14580154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of developing national strategic plans as a guide to strengthen laboratory health systems in resource-poor settings.
    Nkengasong JN; Mesele T; Orloff S; Kebede Y; Fonjungo PN; Timperi R; Birx D
    Am J Clin Pathol; 2009 Jun; 131(6):852-7. PubMed ID: 19461093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of medical diagnostics and medical devices in the East African community partner states.
    Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
    BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving quality in resource poor settings: observational study from rural Rwanda.
    Kotagal M; Lee P; Habiyakare C; Dusabe R; Kanama P; Epino HM; Rich ML; Farmer PE
    BMJ; 2009 Oct; 339():b3488. PubMed ID: 19880528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost valuation in resource-poor settings.
    Hutton G; Baltussen R
    Health Policy Plan; 2005 Jul; 20(4):252-9. PubMed ID: 15965037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
    Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
    Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of abnormal uterine bleeding in low- and high-resource settings: consideration of cultural issues.
    Haththotuwa R; Goonewardene M; Desai S; Senanayake L; Tank J; Fraser IS
    Semin Reprod Med; 2011 Sep; 29(5):446-58. PubMed ID: 22065330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Equipment for diagnostics, laboratory analyses and treatment in out-of-hours services].
    Rebnord IK; Thue G; Hunskår S
    Tidsskr Nor Laegeforen; 2009 May; 129(10):987-90. PubMed ID: 19448751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lab-on-a-chip devices for global health: past studies and future opportunities.
    Chin CD; Linder V; Sia SK
    Lab Chip; 2007 Jan; 7(1):41-57. PubMed ID: 17180204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A].
    Sun Q; Yan L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):43-52. PubMed ID: 16646425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings.
    Beran D; Yudkin JS
    Diabetes Res Clin Pract; 2010 Jun; 88(3):217-21. PubMed ID: 20447710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.